Literature DB >> 2384923

Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript.

J H Ou1, H Bao, C Shih, S M Tahara.   

Abstract

In the human hepatitis B virus (HBV) genome, the 5' end of the polymerase coding sequence overlaps with the 3' end of the core protein coding sequence. Recent results obtained from genetic studies have suggested that translation of HBV polymerase initiates from the first ATG codon of the polymerase reading frame and is not a result of frameshift translation from the core protein reading frame, as in the case of retroviruses. By using in vitro-synthesized SP6 RNA transcripts, we now demonstrate that HBV core protein-specific mRNA can direct the synthesis of polymerase from the internal polymerase ATG codon in rabbit reticulocyte lysates and Xenopus oocytes. A related message with an additional 60 nucleotides at the 5' end (pre-core protein mRNA) was not as efficient as the core protein mRNA for translation of polymerase. Furthermore, translation of polymerase from the core protein mRNA was not inhibited by the cap analog m7GpppG. This result, together with the results described above, indicates that translation of HBV polymerase occurs in a novel, cap-independent manner.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384923      PMCID: PMC247932     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  cis rescue of a mutated reverse transcriptase gene of human hepatitis B virus by creation of an internal ATG.

Authors:  S Roychoudhury; C Shih
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting.

Authors:  T Jacks; H E Varmus
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

3.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 4.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation.

Authors:  J M Lien; D J Petcu; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant.

Authors:  G H Enders; D Ganem; H Varmus
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

9.  Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle.

Authors:  D N Standring; J H Ou; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Cloning and characterization of a human ribosomal protein gene with enhanced expression in fetal and neoplastic cells.

Authors:  J H Ou; T S Yen; Y F Wang; W K Kam; W J Rutter
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

View more
  34 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus.

Authors:  S Roychoudhury; A F Faruqi; C Shih
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Sequential partially overlapping gene arrangement in the tricistronic S1 genome segments of avian reovirus and Nelson Bay reovirus: implications for translation initiation.

Authors:  Maya Shmulevitz; Zareen Yameen; Sandra Dawe; Jingyun Shou; David O'Hara; Ian Holmes; Roy Duncan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus.

Authors:  J Summers; P M Smith; M J Huang; M S Yu
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995

9.  Detection of an RNase H activity associated with hepadnaviruses.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 10.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.